<- Go Home
Locust Walk Acquisition Corp.
As of August 25, 2021, Locust Walk Acquisition Corp. was acquired by eFFECTOR Therapeutics, Inc., in a reverse merger transaction.
Market Cap
$599.8M
Volume
N/A
Cash and Equivalents
$12.0K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$40.42
52 Week Low
$8.33
Dividend
N/A
Price / Book Value
4.6K
Price / Earnings
N/A
Price / Tangible Book Value
4.6K
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$8.0K
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
$12.0K
Debt
$60.4K
Equity
$23.0K
Revenue
N/A
Unlevered FCF
N/A
Sector
Capital Markets
Category
N/A